Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
In Vitro Evaluation of Dexmedetomidine on Pregnant Human Myometrium Contractility
NCT05511415Completed
- Sponsor
- Mount Sinai Hospital
- Start
- Nov 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine in postpartum hemorrhage (PPH), sponsored by Mount Sinai Hospital. Primary endpoint: Motility index at 4 hours. Started Nov 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT05511415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05511415.